Monograph 0478 mandates several critical tests to ensure batch-to-batch consistency:
Monograph 0478 also provides additional requirements for specialized tablet types: European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-
| Issue | Guidance | |-------|----------| | | Use a balance with appropriate precision (≥ 0.1 mg for < 50 mg tablets). | | Coated tablet friability | Not required by 0478, but may be requested by regulators if coating chips. | | Disintegration vs dissolution | Disintegration does not guarantee dissolution; dissolution is the definitive performance test. | | Uniformity of dosage units – mass variation eligibility | Check if active ingredient is ≥ 90% of core mass; otherwise, content uniformity is mandatory. | | Sugar-coated tablets disintegration | Time starts when tablet is placed in apparatus; coating must rupture within a few minutes. | Monograph 0478 mandates several critical tests to ensure
Based on FDA and EMA warning letters citing Ph. Eur. 0478 (or equivalent national requirements), here are the top 5 failures: | | Uniformity of dosage units – mass
More than just a checklist, this monograph is the "constitution" for solid dosage forms in Europe. It is a masterclass in balancing contradictory physical forces—hardness versus friability, stability versus solubility. Let’s dissect what makes this document the silent guardian of pharmaceutical quality.